Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.

Site Map

Site Map of http://www.researchandmarkets.com


Site Map
Pharmaceuticals and Healthcare
   Pharmaceuticals 1 (Latest Titles)
   Pharmaceuticals 2
   Pharmaceuticals 3
   Pharmaceuticals 4

      Generics  << You are in This Category




#  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  


A

ACE Inhibitor Intolerance: A major driver of growth for the Aiirbs static version printer friendly pdf version
Actavis IMS Company Profile static version printer friendly pdf version
An Exploration of Consolidation in the Generics Industry static version printer friendly pdf version
Anti-hypertensives: Patent Defense Strategies - Combating Generic Competition Through Lifecycle Management static version printer friendly pdf version
Asia-Pacific Generics static version printer friendly pdf version
Authorized Generics: Look Before you Leap static version printer friendly pdf version
Average Cost of Brand and Generic Drugs static version printer friendly pdf version


^ Top



B

Barr: PharmaVitae Generics Profile static version printer friendly pdf version
Biogenerics: Challenges and Promise static version printer friendly pdf version
Booming US Generic Drug Market static version printer friendly pdf version
Business Strategies for Different Types of Biogenerics static version printer friendly pdf version


^ Top



C

CNS Generic Drugs: Prospects and Opportunities to 2012 static version printer friendly pdf version
CNS Year in Review: 2001 static version printer friendly pdf version
Combating Generics 2008: Counter-Generics Strategy, Tactics and Execution static version printer friendly pdf version
Commercial Insight: Antibacterials - Regulations, Resistance & Generics static version printer friendly pdf version
Commercial Insight: Migraine - Opportunities will Exist in the Wake of Generic Attack static version printer friendly pdf version
Competitor Analysis: Biogenerics & Therapeutic Proteins static version printer friendly pdf version
Current Cardiovascular and Diabetes Blockbusters - Brands at Risk Beware static version printer friendly pdf version


^ Top



D

Drug Delivery 2000: A Key Company and Market Analysis static version printer friendly pdf version
Drugs of Tommorrow 2002: Pain static version printer friendly pdf version
Drugs of Tomorrow 2001: Bacterial Infections static version printer friendly pdf version


^ Top



E

Emerging Generic Drug Companies Worldwide 2007 static version printer friendly pdf version
Emerging Opportunities in Inhalation & Nasal Spray Generic Drugs static version printer friendly pdf version
European Generic Gastrointestinal Pharmaceutical Markets static version printer friendly pdf version
European Generics static version printer friendly pdf version


^ Top



F

Follow-On Products as a Defense Against Generics static version printer friendly pdf version
Front-End Strategies to Meet Generics Challenges and Reduce Pharmaceutical Risk static version printer friendly pdf version
Future Growth Opportunities in Generics: The Impact of Consolidation on Market and Competitive Dynamics static version printer friendly pdf version


^ Top



G

Generic Drug Market in Canada static version printer friendly pdf version
Generic Drug Share of Total Market, 1984-2020 static version printer friendly pdf version
Generic Drugs: Technology, Trends, and Opportunities static version printer friendly pdf version
Generic Handbook: A Guide to the Generic Drug Industry in the US, 2007 Edition static version printer friendly pdf version
Generic Pharmaceuticals in Belgium: A Strategic Reference, 2006 static version printer friendly pdf version
Generic Series: An Introduction To The Canadian Generics Market - Key Trends And Leading Companies Shaping The Market static version printer friendly pdf version
Generics Defense Strategies: Effective Brand Protection through Patent, Formulation, OTC and DTC Strategies static version printer friendly pdf version
Generics Erosion Patterns in the U.S. Market static version printer friendly pdf version
Generics in Asia-Pacific static version printer friendly pdf version
Generics in Belgium static version printer friendly pdf version
Generics in Canada static version printer friendly pdf version
Generics in China static version printer friendly pdf version
Generics in Europe static version printer friendly pdf version
Generics in France static version printer friendly pdf version
Generics in Germany static version printer friendly pdf version
Generics in Italy static version printer friendly pdf version
Generics in Japan static version printer friendly pdf version
Generics in Spain static version printer friendly pdf version
Generics in the Animal Health Industry static version printer friendly pdf version
Generics in the Netherlands static version printer friendly pdf version
Generics in the United Kingdom static version printer friendly pdf version
Generics in the United States static version printer friendly pdf version
Generics Review 2000/ 2001 static version printer friendly pdf version
Generics Substitution in the Spotlight static version printer friendly pdf version
Generics will Play an Increasingly Important Role in the Pharma Industry static version printer friendly pdf version
Generics: Global Industry Guide static version printer friendly pdf version
Global Generics static version printer friendly pdf version
Global Generics static version printer friendly pdf version
Global Generics Guide 3rd Edition: Benchmarking Generics Company Capabilities and Strategy static version printer friendly pdf version
Global Generics Guide: Benchmarking the Key Players static version printer friendly pdf version
Global Generics Guide: Capitalizing On an $82 Billion Opportunity static version printer friendly pdf version
Global Generics Guide: Part 2 - Benchmarking Country Markets and Strategic Issues static version printer friendly pdf version
Global Generics Industry Report static version printer friendly pdf version
Global Healthcare Review - October 2002 static version printer friendly pdf version
Global Healthcare Review - September 2002 static version printer friendly pdf version
Growth Strategies In Generics: Innovative And Aggressive Strategies And Their Impact On Branded Pharmaceuticals static version printer friendly pdf version


^ Top



H

Healthcare Review: Immune Disorders and Inflammation - September 2002 static version printer friendly pdf version
Healthcare Review: Infectious Diseases - October 2002 static version printer friendly pdf version
Healthcare Review: Licensing - October 2002 static version printer friendly pdf version
Hepatitis C virus (HCV) - Fierce Competition for a Shrinking HCV Market?  static version printer friendly pdf version
Hormonal Contraception: Market Update - Surviving the Generic Threat static version printer friendly pdf version
Human Growth Hormone - Delivery Technology Driving Market Growth static version printer friendly pdf version


^ Top



I

Impact of Generics on the Antidepressant Market static version printer friendly pdf version
Indian Generics, 2008-2012: The Growing Threat to Westernised Markets static version printer friendly pdf version
Indian Global Generics Market Size, 2003-2010 static version printer friendly pdf version
Injectable Generic Drugs: Prospects and Opportunities to 2010 static version printer friendly pdf version


^ Top



M

Market Dynamics 2001: Anti-hypertensives - Aiirbs battle for supremacy static version printer friendly pdf version
Market Dynamics 2001: Antidepressants - Absorbing the Impact of Generic Prozac static version printer friendly pdf version
Market Dynamics 2001: Hormonals static version printer friendly pdf version
Market Dynamics: HIV - Combating a Market Slowdown static version printer friendly pdf version
Maximising the Drug Lifecycle static version printer friendly pdf version
Mylan: PharmaVitae Generics Profile static version printer friendly pdf version


^ Top



N

New Dynamics and Challenges in the Generics Market 2007 static version printer friendly pdf version


^ Top



O

Opportunities and Challenges for Bioequivalent Generic Drugs in Brazil static version printer friendly pdf version


^ Top



P

Pharaceutical Branding Strategies static version printer friendly pdf version
Population Genetics and Microevolutionary Theory static version printer friendly pdf version
Practical Defense Strategies for Combating Generics Competition static version printer friendly pdf version
Pricing and Reimbursement Issues for Generics and Biosimilars static version printer friendly pdf version


^ Top



R

Reimbursement in Europe, Japan and the US: The Impact of Cost Shifting on Pharmaceutical Strategies static version printer friendly pdf version
Retail Pharmacy Price Markups on Generic Drugs static version printer friendly pdf version


^ Top



S

Sandoz - PharmaVitae Generics Profile static version printer friendly pdf version
SPECIAL REPORT: Patterns of Generic Erosion: An International Chartbook static version printer friendly pdf version
Strategic Intelligence: The Top 12 Pharmaceutical Companies static version printer friendly pdf version
Strategic Perspectives 2001: Portfolio Management in the Anti-Fungal Market static version printer friendly pdf version
Strategic Perspectives: Allergic Rhinitis - Impact of a blockbuster going bust static version printer friendly pdf version
Strategic Perspectives: Impact of the Cancer Generics Market static version printer friendly pdf version
Strategies for Biogeneric Success static version printer friendly pdf version


^ Top



T

The Anemia Market: Biogenerics and Second-Generation Products Drive Change static version printer friendly pdf version
The Biogenerics Market Outlook: An Analysis of Market Dynamics, Growth Drivers and Leading Players static version printer friendly pdf version
The Blockbuster Drugs Outlook: Optimum management strategies throughout the product lifecycle static version printer friendly pdf version
The European Generics Outlook: A Country-By-Country Analysis Of Developing Market Opportunities And Revenue Defense Strategies static version printer friendly pdf version
The Generics Industry in 2005: A New Threat to Pharma static version printer friendly pdf version
The Generics Outlook 2001 static version printer friendly pdf version
The Latin American Market for Generic Drugs - A Comparative Study of 7 Key Markets static version printer friendly pdf version
The Pharmaceuticals Industry Market Review static version printer friendly pdf version
The Top 10 Generics Companies: Strategic Insight, Growth Opportunities and Competitive Dynamics in the US and Europe static version printer friendly pdf version
The World Generic Market Report 2008 static version printer friendly pdf version
Therapeutic Proteins: Strategic Market Analysis and Forecasts to 2010 static version printer friendly pdf version
Toward a Biogenerics Market: The Regulatory Conundrum static version printer friendly pdf version


^ Top



U

U.S. Drug Delivery Systems Market: Emerging Technologies, Strategic Alliances, Patent Disputes, Market Size and Forecasts and R&D Activities static version printer friendly pdf version
U.S. Generic Pharmaceuticals Outlook static version printer friendly pdf version
Update on Dermatology Market static version printer friendly pdf version
US and European Prescription Generic Markets: An Examination of Commercial and Regulatory Contrasts static version printer friendly pdf version


^ Top



W

World Generic Drug Markets: Competitive Benchmarking static version printer friendly pdf version
World Generics and Biogenerics Markets static version printer friendly pdf version

All rights reserved. © copyright 2006 Research and Markets
Terms and conditions Privacy Policy